Literature DB >> 4360858

Sequence of events mediating the effect of cholera toxin on rat thymocytes.

J M Boyle, J D Gardner.   

Abstract

We have found that in rat thymocytes binding of [(125)I]choleragen is followed by cellular accumulation of cyclic 3',5'-AMP which, in turn, is followed by stimulation of amino acid transport. Binding of cholera toxin was complete by 30 min and remained constant for the subsequent 150 min. After stimulation by choleragen, cellular cyclic 3',5'-AMP became maximal by 30 min, after which it declined steadily so that by 90 min of incubation, cellular cyclic nucleotide levels were only 20% of those seen at 30 min. Stimulation of amino acid transport, although detectable by 15 min, did not become maximal until 120 min (by which time cellular cyclic 3',5'-AMP had decreased by more than 80%). We have also used this system to delineate the step at which various pharmacologic agents and hormones act to alter the sequence of events mediating the response of rat thymocytes to cholera toxin. The ability of cycloheximide to abolish choleragen-stimulated amino acid influx without reducing [(125)I]choleragen binding or cellular cyclic 3',5'-AMP suggests that cyclic nucleotide stimulation of amino acid transport includes a step involving protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4360858      PMCID: PMC333101          DOI: 10.1172/JCI107653

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Localization of cholera toxin in vivo.

Authors:  J W Peterson; J J LoSpalluto; R A Finkelstein
Journal:  J Infect Dis       Date:  1972-12       Impact factor: 5.226

2.  Insulin action in isolated rat thymocytes. II. Independence of insulin and cyclic adenosine monophosphate.

Authors:  I D Goldfine; P Sherline
Journal:  J Biol Chem       Date:  1972-11-10       Impact factor: 5.157

3.  Stimulation of glycerol production in fat cells by cholera toxin.

Authors:  M Vaughan; N F Pierce; W B Greenough
Journal:  Nature       Date:  1970-05-16       Impact factor: 49.962

4.  Gangliosides and membrane receptors for cholera toxin.

Authors:  P Cuatrecasas
Journal:  Biochemistry       Date:  1973-08-28       Impact factor: 3.162

5.  Vibrio cholerae choleragenoid. Mechanism of inhibition of cholera toxin action.

Authors:  P Cuatrecasas
Journal:  Biochemistry       Date:  1973-08-28       Impact factor: 3.162

6.  Titration of cholera antitoxin levels by passive hemagglutination tests using fresh and formalinized sheep erythrocytes.

Authors:  H D Hochstein; J C Feeley; S H Richardson
Journal:  Proc Soc Exp Biol Med       Date:  1970-01

7.  Effects of prostaglandins, theophylline, and cholera exotoxin upon transmucosal water and electrolyte movement in the canine jejunum.

Authors:  N F Pierce; C C Carpenter; H L Elliott; W B Greenough
Journal:  Gastroenterology       Date:  1971-01       Impact factor: 22.682

8.  Inhibition of cholera toxin action in the rabbit by cycloheximide.

Authors:  H A Serebro; F L Iber; J H Yardley; T R Hendrix
Journal:  Gastroenterology       Date:  1969-03       Impact factor: 22.682

9.  Effects of cholera toxin on in vitro models of immediate and delayed hypersensitivity. Further evidence for the role of cyclic adenosine 3',5'-monophosphate.

Authors:  L M Lichtenstein; C S Henney; H R Bourne; W B Greenough
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

10.  Effects of cholera enterotoxin on adenosine 3',5'-monophosphate and neutrophil function. Comparison with other compounds which stimulate leukocyte adenyl cyclase.

Authors:  H R Bourne; R I Lehrer; L M Lichtenstein; G Weissmann; R Zurier
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

View more
  10 in total

1.  Studies on the time course and rate-limiting steps in the activation of adenylate cyclase in rat liver by cholera toxin.

Authors:  J Fischer; T R Kohler; L G Lipson; J Flores; P A Witkum; G W Sharp
Journal:  Biochem J       Date:  1978-07-01       Impact factor: 3.857

2.  Mechanism of activation of adenylate cyclase by Vibrio cholerae enterotoxin. Relations to the mode of activation by hormones.

Authors:  V Bennett; L Mong; P Cuatrecasas
Journal:  J Membr Biol       Date:  1975-11-07       Impact factor: 1.843

3.  Mode of action of cholera toxin: stabilization of catecholamine-sensitive adenylate cyclase in turkey erythrocytes.

Authors:  M Field
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

4.  Cytotoxic effect of Mycoplasma fermentans on mouse thymocytes.

Authors:  M G Gabridge; P R Schneider
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

5.  Stimulation of cyclic AMP secretion in Vero cells by enterotoxins of Escherichia coli and Vibrio cholerae.

Authors:  S Stavric; J I Speirs; J Konowalchuk; D Jeffrey
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

6.  Action of cholecystokinin and cholinergic agents on calcium transport in isolated pancreatic acinar cells.

Authors:  J D Gardner; T P Conlon; H L Kleveman; T D Adams; M A Ondetti
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

7.  Mechanism of action of Vibrio cholerae enterotoxin. Effects on adenylate cyclase of toad and rat erythrocyte plasma membranes.

Authors:  V Bennett; P Cuatrecasas
Journal:  J Membr Biol       Date:  1975-06-03       Impact factor: 1.843

8.  Comparison of the action of Escherichia coli enterotoxin on the thymocyte adenylate cyclase-cyclic adenosine monophosphate system to that of cholera toxin and prostaglandin E1.

Authors:  T V Zenser; J F Metzger
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

9.  Purification of tritium-labeled cholera toxin.

Authors:  J G Banwell; D W Hanke; D Diedrich
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

10.  Mechanism of activation of adenylate cyclase by cholera toxin.

Authors:  N Sahyoun; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.